ID
44776
Descrizione
Study of STA-1 as an Add-on Treatment to Donepezil; ODM derived from: https://clinicaltrials.gov/show/NCT01255046
collegamento
https://clinicaltrials.gov/show/NCT01255046
Keywords
versioni (3)
- 30/08/15 30/08/15 -
- 13/04/21 13/04/21 - Dr. rer. medic Philipp Neuhaus
- 18/11/21 18/11/21 -
Titolare del copyright
Sinphar Pharmaceutical Co., Ltd
Caricato su
18 novembre 2021
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Alzheimer Disease NCT01255046
Eligibility Alzheimer Disease NCT01255046
- StudyEvent: Eligibility
Descrizione
Exclusion Criteria
Descrizione
brain image (computed tomography (ct) scan or magnetic resonance imaging (mri) done within past 12 months prior to the study) and laboratory tests to exclude secondary dementia or non-alzheimer's dementia;
Tipo di dati
boolean
Alias
- UMLS CUI [1]
- C0024485
- UMLS CUI [2]
- C0040405
- UMLS CUI [3]
- C0587081
Descrizione
patient with significant clinically central nervous system illness other than ad (e.g. parkinson's disease, human immunodeficiency virus (hiv) induced dementia, hachinski ischaemic score (his) >4) or dementia complicated by other organic disease or delirium;
Tipo di dati
boolean
Alias
- UMLS CUI [1]
- C0007682
Descrizione
patient with a severe or uncontrolled diagnostic and statistical manual of mental disorders (dsm-iv) axis i disorder other than alzheimer's disease, including amnestic disorders, schizophrenia or schizoaffective disorder, bipolar disorder, current major depressive episode, psychosis, panic, or post-traumatic stress disorder;
Tipo di dati
boolean
Alias
- UMLS CUI [1]
- C0004936
Descrizione
patient suffering from cerebral disturbances following a stroke or a cerebral trauma (if the event occurred within the last 6 months);
Tipo di dati
boolean
Alias
- UMLS CUI [1,1]
- C0038454
- UMLS CUI [1,2]
- C0234387
- UMLS CUI [2,1]
- C0018674
- UMLS CUI [2,2]
- C0234387
Descrizione
patient with a history of hypersensitivity to study drugs;
Tipo di dati
boolean
Alias
- UMLS CUI [1]
- C0013182
Descrizione
patient who has a history or evidence of a medical condition that would expose them to an undue risk of a significant adverse event or interfere with assessments of safety or efficacy during the course of the trial, including but not limited to hepatic, renal, respiratory, cardiovascular, endocrine (e.g., addison's disease), immune, neurologic, or hematologic disease as determined by the clinical judgment of the investigator;
Tipo di dati
boolean
Alias
- UMLS CUI [1]
- C3843040
Descrizione
participation in any research study within the last 30 days;
Tipo di dati
boolean
Alias
- UMLS CUI [1]
- C0008976
Descrizione
patient with significant alcohol or drug abuse as judged by the investigator.
Tipo di dati
boolean
Alias
- UMLS CUI [1]
- C0237123
Similar models
Eligibility Alzheimer Disease NCT01255046
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C0038454 (UMLS CUI [2])
C0677408 (UMLS CUI [2])
C0040405 (UMLS CUI [2])
C0587081 (UMLS CUI [3])
C0234387 (UMLS CUI [1,2])
C0018674 (UMLS CUI [2,1])
C0234387 (UMLS CUI [2,2])